Loading…
Reported covered position: COUNSEL/SEN PERM SUBCOMM ON INVEST
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FAIR Act
Client: ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) · Firm: WILLIAMS AND JENSEN, PLLC
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage program. Telehealth policies. H.R. 3417.
FAIR Act
Client: ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) · Firm: WILLIAMS AND JENSEN, PLLC
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Policies impacting U.S. address to the Covid-19 pandemic. Telehealth policies. H.R. 3417.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SANOFI, U.S. via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
Source: Senate LDA
| NOVARTIS, INC. |
| 53 |
| 2000–2017 |
| TAKEDA PHARMACEUTICALS AMERICA INC | 52 | 2007–2021 |
| NATIONAL ASSN OF STATE TREASURERS (NAST) | 49 | 2005–2017 |
| AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) | 48 | 2012–2023 |
| ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) | 48 | 2000–2016 |
| ZOETIS | 45 | 2013–2022 |
| ELI LILLY & COMPANY | 43 | 2014–2024 |
| BAYER CORPORATION | 41 | 2001–2023 |
| HOUSTON FIREFIGHTERS RELIEF AND RETIREMENT FUND | 40 | 2005–2016 |
| SHIRE PHARMACEUTICALS LLC FORMERLY KNOWN AS SHIRE REGENERATIVE MEDICINE | 39 | 2010–2019 |
| SUNOCO INC | 36 | 2004–2015 |
| COCA-COLA COMPANY | 34 | 2002–2016 |
| AMGEN, INC. | 32 | 2004–2024 |
| INDIVIOR INC. | 32 | 2017–2024 |
| MT PHARMA AMERICA, INC. | 32 | 2017–2024 |
| BROOKS BROTHERS | 31 | 2003–2018 |
| SUPIMA | 31 | 2010–2018 |
| Buhler Quality Yarns Corporation | 30 | 2010–2018 |
| GITMAN AND COMPANY | 30 | 2010–2018 |
| NEWS MEDIA ALLIANCE | 30 | 2017–2024 |
| SANOFI, U.S. | 30 | 2017–2024 |
| SOUTHWICK CLOTHING, LLC. | 30 | 2010–2018 |
| Tom James Company | 30 | 2010–2018 |
| ABBOTT LABORATORIES | 29 | 2000–2013 |
| VISA | 29 | 2011–2017 |
| RESEARCH SOCIETY ON ALCOHOL (FORMERLY KNOWNS AS RESEARCH SOCIETY ON ALCOHOLISM) | 28 | 2005–2024 |
| WINE AND SPIRITS WHOLESALERS OF AMERICA | 28 | 2010–2016 |
| BRICKSTREET MUTUAL INSURANCE COMPANY | 25 | 2010–2016 |
| TRANSAMERICA COMPANIES (FORMLY AEGON) | 25 | 2002–2012 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 23 | 2001–2024 |
| AMERICAN COUNCIL OF LIFE INSURERS | 22 | 2003–2012 |
| OWENS-ILLINOIS INC | 22 | 2003–2012 |
| AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY | 21 | 2008–2013 |
| NOVO NORDISK, INC. | 21 | 2020–2024 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | 20 | 2018–2023 |
| OHIO POLICE AND FIRE PENSION FUND | 20 | 2012–2017 |
| PROPERTY CASUALTY INSURERS ASSOCIATION OF AMERICA | 20 | 2015–2019 |
| WYETH (FORMERLY AMERICAN HOME PRODUCTS) | 20 | 2001–2009 |
| UNITED AIRLINES, INC | 19 | 2005–2011 |
| COTIVITI CORPORATION (FORMERLY CONNOLLY LLC - IHEALTH TECHNOGIES INC ) | 18 | 2015–2019 |
| AIR MEDICAL OPERATORS ASSOCIATION | 17 | 2009–2018 |
| IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) | 17 | 2020–2024 |
| TTX COMPANY | 16 | 2010–2014 |
| MANAGED FUNDS ASSOCIATION | 15 | 2008–2012 |
| AMERICAN ASSOCIATION OF RETIRED PERSONS | 14 | 2010–2013 |
| BIOGEN IDEC | 14 | 2014–2017 |
| WOMEN'S HEALTH COALITION | 14 | 2017–2020 |
| CHURCH ALLIANCE | 13 | 2004–2011 |
| INFECTIOUS DISEASES SOCIETY OF AMERICA | 13 | 2014–2017 |
| INTUIT | 13 | 2008–2011 |
| IRHYTHM TECHNOLOGIES | 13 | 2021–2024 |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS | 13 | 2004–2009 |
| COMCAST CORPORATION | 12 | 2014–2016 |
| US AGAINST ALZHEIMER'S | 12 | 2018–2021 |
| AMERICAN WAGERING INC DBA WILLIAM HILL US (DBA AMERICAN WAGING INC DBA WILLIA) | 10 | 2018–2019 |
| CEPHALON, INC. | 10 | 2009–2011 |
| HMX LLC | 10 | 2010–2013 |
| FAGRON NORTH AMERICA | 9 | 2015–2016 |
| ORGANON | 9 | 2022–2024 |
| OSIRIS THERAPEUTICS INC | 9 | 2014–2016 |
| CIGNA CORP | 8 | 2002–2006 |
| INTERNATIONAL ASSOCIATION OF AMUSEMENT PARKS AND ATTRACTIONS | 8 | 2009–2012 |
| ALLIANCE FOR OUTPATIENT REHABILITATION QUALITY AND ACCESS | 7 | 2006–2008 |
| AMERICAN BUSINESS GROUP OF ABU DHABI (D/B/A AMCHAM ABU DHABI) | 7 | 2015–2016 |
| PHARMACY SERVICES | 7 | 2013–2014 |
| RECORDING INDUSTRY ASSN OF AMERICA | 7 | 2009–2011 |
| REINSURANCE ASSOCIATION OF AMERICA | 7 | 2020–2021 |
| AMERICAN AUTOMOTIVE POLICY COUNCIL | 6 | 2017 |
| DNV HEALTHCARE | 6 | 2008–2009 |
| ECRI INSTITUTE | 6 | 2018–2019 |
| INDICIUM GROUP | 6 | 2019–2020 |
| NORTHFIELD LABORATORIES | 6 | 2006–2008 |
| CONSUMER CREDIT COUNSELING SERVICE OF THE MIDWEST | 5 | 2005–2006 |
| MEMORIAL HEALTH UNIV MEDICAL CENTER | 5 | 2005–2007 |
| THE JED FOUNDATION | 5 | 2023–2024 |
| UNITED COMPOUNDING MANAGEMENT, LLC | 5 | 2014–2015 |
| AMERICAN AIRLINES, INC. | 4 | 2024 |
| AMERICAN PHYSICAL THERAPY ASSN | 4 | 2003–2005 |
| CENTER FOR PRISON REFORM | 4 | 2014–2015 |
| CITY OF CEDAR RAPIDS, IA | 4 | 2010–2011 |
| EISAI CORPORATION OF NORTH AMERICA | 4 | 2009–2010 |
| HOFFMAN-LA ROCHE | 4 | 2006–2007 |
| PYRAMID MANAGEMENT GROUP INC | 4 | 2002–2005 |
| RAYNER | 4 | 2023–2024 |
| THE GREAT OUTDOORS FOUNDATION | 4 | 2023–2024 |
| THE IMMIGRATION HUB | 4 | 2021 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | 2020–2023 |
| WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS) | 4 | 2024 |
| APPLERA CORP | 3 | 2000–2002 |
| DR. EMIL KAKKIS | 3 | 2023–2024 |
| EDUCATION FINANCE COUNCIL | 3 | 2003–2004 |
| THE DAVIS BROWN LAW FIRM ON BEHALF OF POLK COUNTY IA | 3 | 2020 |
| CREDIT SUISSE FIRST BOSTON | 2 | 2004–2005 |
| ENDOCARE INC | 2 | 2009 |
Flood Resiliency and Land Stewardship Act
Client: THE GREAT OUTDOORS FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
2024 Farm Bill (H.R. 8467). "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2024 RCPP grants.
Flood Resiliency and Land Stewardship Act
Client: THE GREAT OUTDOORS FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
2023 Farm Bill. "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2023 RCPP grants.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024
Client: IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) · Firm: WILLIAMS AND JENSEN, PLLC
Funding for river improvements, including modification of dams. Fiscal Year 2024 Transportation-HUD appropriations (H.R. 4820), including community project funding for the Fleur Drive Dam project. Fiscal Year 2025 Transportation-HUD appropriations, include community project funding for Prospect Park. Implementation of BUILD Grant. Water Resources Development Act.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024
Client: IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) · Firm: WILLIAMS AND JENSEN, PLLC
Funding for river improvements, including modification of dams. Fiscal Year 2024 Transportation-HUD appropriations (H.R. 4820) and FY 2024 Consolidated Appropriations Act (P.L. 118-42), including community project funding for Fleur Drive Dam. Fiscal Year 2025 Transportation-HUD appropriations, include community project funding for Prospect Park. Implementation of BUILD Grant. Water Resources Development Act.
EMPOWER Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
EMPOWER Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
EMPOWER Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Enhancing Mental Health and Suicide Prevention Through Campus Planning Act
Client: THE JED FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act.
Enhancing Mental Health and Suicide Prevention Through Campus Planning Act
Client: THE JED FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act.
Enhancing Mental Health and Suicide Prevention Through Campus Planning Act
Client: THE JED FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act. S.1409--Kids Online Safety Act.
Enhancing Mental Health and Suicide Prevention Through Campus Planning Act
Client: THE JED FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act. S.1409--Kids Online Safety Act.
Regional Conservation Partnership Program (RCPP) and 2023 RCPP grants, wetlands and clean water programs. Mississippi River/Gulf of Mexico Hypoxia Task Force. "Mississippi River Restoration and Resilience Initiative (MRRRI) Act" (H.R. 7289, S. 3754).
Regional Conservation Partnership Program (RCPP) and 2024 RCPP grants, wetlands and clean water programs. Mississippi River/Gulf of Mexico Hypoxia Task Force. "Mississippi River Restoration and Resilience Initiative (MRRRI) Act" (H.R. 7289, S. 3754).
Farm, Food, and National Security Act of 2024
Client: THE GREAT OUTDOORS FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
2024 Farm Bill (H.R. 8467). "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2024 RCPP grants.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2025
Client: IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) · Firm: WILLIAMS AND JENSEN, PLLC
Funding for river improvements, including modification of dams. Implementation of FY 2024 Consolidated Appropriations Act (P.L. 118-42), including community project funding for Fleur Drive Dam. Fiscal Year 2025 Transportation-HUD appropriations (H.R. 9028), include community project funding for Prospect Park. Implementation of BUILD Grant. Water Resources Development Act.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers. Artificial Intelligence policies.
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act. S.1409--Kids Online Safety Act.
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act. S.1409--Kids Online Safety Act.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act of 2023
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Regional Conservation Partnership Program (RCPP) and 2024 RCPP grants, wetlands and clean water programs. Mississippi River/Gulf of Mexico Hypoxia Task Force. "Mississippi River Restoration and Resilience Initiative (MRRRI) Act" (H.R. 7289, S. 3754).
Regional Conservation Partnership Program (RCPP) and 2023 RCPP grants, wetlands and clean water programs. Mississippi River/Gulf of Mexico Hypoxia Task Force. "Mississippi River Restoration and Resilience Initiative (MRRRI) Act" (H.R. 7289, S. 3754).
I CAN Act
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
I CAN Act
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Flood Resiliency and Land Stewardship Act
Client: THE GREAT OUTDOORS FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
2023 Farm Bill. "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2023 RCPP grants.
Flood Resiliency and Land Stewardship Act
Client: THE GREAT OUTDOORS FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
2023 Farm Bill. "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2023 RCPP grants.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024
Client: IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) · Firm: WILLIAMS AND JENSEN, PLLC
Funding for river improvements, including modification of dams. Fiscal Year 2024 Transportation-HUD appropriations (H.R. 4820), including community project funding for the Fleur Drive Dam project. Implementation of BUILD Grant.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024
Client: IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) · Firm: WILLIAMS AND JENSEN, PLLC
Funding for river improvements, including modification of dams. Fiscal Year 2024 Transportation-HUD appropriations (H.R. 4820), including community project funding for the Fleur Drive Dam project. Implementation of BUILD Grant.
EMPOWER Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
EMPOWER Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Enhancing Mental Health and Suicide Prevention Through Campus Planning Act
Client: THE JED FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act.
Enhancing Mental Health and Suicide Prevention Through Campus Planning Act
Client: THE JED FOUNDATION · Firm: WILLIAMS AND JENSEN, PLLC
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act.
Improving Access to Workers’ Compensation for Injured Federal Workers Act
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Improving Access to Workers’ Compensation for Injured Federal Workers Act
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Crime Gun Tracing Modernization Act of 2023
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Crime Gun Tracing Modernization Act of 2023
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Journalism Competition and Preservation Act of 2023
Client: NEWS MEDIA ALLIANCE · Firm: WILLIAMS AND JENSEN, PLLC
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Improving Access to Workers’ Compensation for Injured Federal Workers Act
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Improving Access to Workers’ Compensation for Injured Federal Workers Act
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Workforce Mobility Act of 2023
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Workforce Mobility Act of 2023
Client: AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) · Firm: WILLIAMS AND JENSEN, PLLC
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act
Client: NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES · Firm: WILLIAMS AND JENSEN, PLLC
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Taxpayer Exposure Mitigation Act
Client: ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) · Firm: WILLIAMS AND JENSEN, PLLC
Legislative issues related to insurance markets; ACA implementation issues. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Taxpayer Exposure Mitigation Act
Client: ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) · Firm: WILLIAMS AND JENSEN, PLLC
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Implementation of COVID legislation. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Taxpayer Exposure Mitigation Act
Client: ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) · Firm: WILLIAMS AND JENSEN, PLLC
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Implementation of COVID legislation. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Taxpayer Exposure Mitigation Act
Client: ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) · Firm: WILLIAMS AND JENSEN, PLLC
Legislative issues related to insurance markets; ACA implementation issues. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Taxpayer Exposure Mitigation Act
Client: ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) · Firm: WILLIAMS AND JENSEN, PLLC
Legislative issues related to insurance markets; ACA implementation issues. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Taxpayer Exposure Mitigation Act
Client: ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) · Firm: WILLIAMS AND JENSEN, PLLC
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Implementation of COVID legislation. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
National Digital Reserve Corps Act
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
National Digital Reserve Corps Act
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
National Digital Reserve Corps Act
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
National Digital Reserve Corps Act
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
Cyber Incident Notification Act of 2021
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
Cyber Incident Notification Act of 2021
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Tax issues affecting the pharmaceutical industry including international tax. Vaccine excise tax issues and VICP.
Issues related to pharmaceutical manufacturing and development.
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals. Public Law 118-47.
Issues related to pharmaceutical manufacturing and development. Legislative proposals related to WTO TRIPS Waiver.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug pricing proposals. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). PASTEUR Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47.
IP Protections related to trade agreements; trade policies impacting pharaceutical development. Legislative proposals related to WTO TRIPS Waiver.
Issues related to pharmaceutical manufacturing and development.
Issues related to pharmaceutical development; Policies impacting Medicare Part D; Part B and 340 B programs.
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Support for obesity drug coverage and access.
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
General issues related to patent protections.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Issues related to pharmaceutical manufacturing and development.
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Issues related to pharmaceutical manufacturing and development.
International and domestic tax issues.
Accelerated approval pathway; support for Alzheimer's diagnostics; obesity treatment.
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS) via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health Issues, NDAA; telehealth issues.
Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health Issues, NDAA; telehealth issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases.
Matters affecting plasma donation and potential plasma shortages. Issues related to PAHPA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES, INC. via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Tax issues related to the pharmaceutical industry.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular health.
Policies impacting disease prevention.
IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · Q3
Funding for river improvements, including modification of dams. Implementation of FY 2024 Consolidated Appropriations Act (P.L. 118-42), including community project funding for Fleur Drive Dam. Fiscal Year 2025 Transportation-HUD appropriations (H.R. 9028), include community project funding for Prospect Park. Implementation of BUILD Grant. Water Resources Development Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, U.S. Fish & Wildlife Service (USFWS)
NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · 3T
Proposals to extend coverage and payment for telehealth services after the public health emergency.
Issues related to therapy services and telehealth.
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IRHYTHM TECHNOLOGIES via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · 3T
Issues related to CMS payment policy and telehealth. Issues related to Medicare technology paid pursuant to the Medicare Physician Fee Schedule. Issues related to Covid 19.
Issues related to artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · 3T
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage program. Telehealth policies. H.R. 3417.
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Policies impacting U.S. address to the Covid-19 pandemic. Telehealth policies. H.R. 3417.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MT PHARMA AMERICA, INC. via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · 3T
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases; matters affecting infusion therapies. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDIVIOR, INC. via WILLIAMS AND JENSEN, PLLC
2024 · third_quarter · 3T
Tax credits and tax issues related to the pharmaceutical industry.
General education on issues related to the Drug Enforcement Agency (DEA), issues related to substance abuse addiction and treatment, including NIH/HHS funding levels, Issues related to access to addiction treatments, including telehealth. Support Act Reauthorization.
Medicaid Re-Entry Act, policies related to reimbursement of substance use disorder treatment and the Mainstreaming Addiction Treatment Act.
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Support for obesity drug coverage and access.
General issues related to patent protections.
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
SANOFI, U.S. via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
PFIZER via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Issues related to pharmaceutical manufacturing and development. Legislative proposals related to WTO TRIPS Waiver.
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals. Public Law 118-47.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug pricing proposals. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). PASTEUR Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals. Public Law 118-47.
PHRMA via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Issues related to pharmaceutical manufacturing and development.
IP Protections related to trade agreements; trade policies impacting pharaceutical development. Legislative proposals related to WTO TRIPS Waiver.
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47.
ORGANON via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Issues related to prevention of unintended pregnancy and access to contraceptives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Issues related to pharmaceutical manufacturing and development.
THE GREAT OUTDOORS FOUNDATION via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
2024 Farm Bill (H.R. 8467). "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2024 RCPP grants.
Regional Conservation Partnership Program (RCPP) and 2024 RCPP grants, wetlands and clean water programs. Mississippi River/Gulf of Mexico Hypoxia Task Force. "Mississippi River Restoration and Resilience Initiative (MRRRI) Act" (H.R. 7289, S. 3754).
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Oceanic & Atmospheric Administration (NOAA), SENATE
IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Funding for river improvements, including modification of dams. Fiscal Year 2024 Transportation-HUD appropriations (H.R. 4820) and FY 2024 Consolidated Appropriations Act (P.L. 118-42), including community project funding for Fleur Drive Dam. Fiscal Year 2025 Transportation-HUD appropriations, include community project funding for Prospect Park. Implementation of BUILD Grant. Water Resources Development Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, U.S. Fish & Wildlife Service (USFWS)
WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS) via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health Issues, NDAA; telehealth issues.
Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health Issues, NDAA; telehealth issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Proposals to extend coverage and payment for telehealth services after the public health emergency.
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Issues related to therapy services and telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INDIVIOR, INC. via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
General education on issues related to the Drug Enforcement Agency (DEA), issues related to substance abuse addiction and treatment, including NIH/HHS funding levels, Issues related to access to addiction treatments, including telehealth. Support Act Reauthorization.
Medicaid Re-Entry Act, policies related to reimbursement of substance use disorder treatment and the Mainstreaming Addiction Treatment Act.
Policies impacting access to substance abuse treatment.
IRHYTHM TECHNOLOGIES via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Issues related to artificial intelligence.
Issues related to CMS payment policy and telehealth. Issues related to Medicare technology paid pursuant to the Medicare Physician Fee Schedule. Issues related to Covid 19.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases.
Matters affecting plasma donation and potential plasma shortages. Issues related to PAHPA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES, INC. via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security.
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Policies impacting disease prevention.
Issues related to patent protections.
False Claims Act Amendments.
MT PHARMA AMERICA, INC. via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases; matters affecting infusion therapies. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JED FOUNDATION via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act. S.1409--Kids Online Safety Act.
General education about mental health and suicide prevention programs.
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act.
RESEARCH SOCIETY ON ALCOHOL (FORMERLY KNOWNS AS RESEARCH SOCIETY ON ALCOHOLISM) via WILLIAMS AND JENSEN, PLLC
2024 · second_quarter · Q2
Funding for alcohol research and substance use disorders in FY 2024 House and Senate appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
General issues related to patent protections.
SANOFI, U.S. via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.
RAYNER via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Medicare coverage issue for non-opioid product.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Issues related to pharmaceutical manufacturing and development.
Issues related to pharmaceutical manufacturing and development. Legislative proposals related to WTO TRIPS Waiver.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug pricing proposals. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). PASTEUR Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals. Public Law 118-47.
PHRMA via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47.
Issues related to pharmaceutical manufacturing and development.
IP Protections related to trade agreements; trade policies impacting pharaceutical development. Legislative proposals related to WTO TRIPS Waiver.
ORGANON via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Issues related to prevention of unintended pregnancy and access to contraceptives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEWS MEDIA ALLIANCE via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers. Artificial Intelligence policies.
DR. EMIL KAKKIS via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
FDA regulatory review and approval issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Issues related to pharmaceutical manufacturing and development.
Issues related to pharmaceutical manufacturing and development.
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Policies impacting U.S. address to the Covid-19 pandemic. Telehealth policies.
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage program. Telehealth policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE GREAT OUTDOORS FOUNDATION via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Regional Conservation Partnership Program (RCPP) and 2023 RCPP grants, wetlands and clean water programs. Mississippi River/Gulf of Mexico Hypoxia Task Force. "Mississippi River Restoration and Resilience Initiative (MRRRI) Act" (H.R. 7289, S. 3754).
2023 Farm Bill. "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2023 RCPP grants.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Oceanic & Atmospheric Administration (NOAA), SENATE
IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Funding for river improvements, including modification of dams. Fiscal Year 2024 Transportation-HUD appropriations (H.R. 4820), including community project funding for the Fleur Drive Dam project. Fiscal Year 2025 Transportation-HUD appropriations, include community project funding for Prospect Park. Implementation of BUILD Grant. Water Resources Development Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, U.S. Fish & Wildlife Service (USFWS)
WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS) via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health Issues, NDAA; telehealth issues.
Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health Issues, NDAA; telehealth issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Proposals to extend coverage and payment for telehealth services after the public health emergency.
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Issues related to therapy services and telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INDIVIOR, INC. via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
General education on issues related to the Drug Enforcement Agency (DEA), issues related to substance abuse addiction and treatment, including NIH/HHS funding levels, Issues related to access to addiction treatments, including telehealth. Support Act Reauthorization.
Medicaid Re-Entry Act, policies related to reimbursement of substance use disorder treatment and the Mainstreaming Addiction Treatment Act.
Tax credits and tax issues related to the pharmaceutical industry.
IRHYTHM TECHNOLOGIES via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Issues related to CMS payment policy and telehealth. Issues related to Medicare technology paid pursuant to the Medicare Physician Fee Schedule. Issues related to Covid 19.
Issues related to artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases.
Matters affecting plasma donation and potential plasma shortages. Issues related to PAHPA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES, INC. via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security.
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies.
Issues related to antitrust legislation
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular health.
MT PHARMA AMERICA, INC. via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases; matters affecting infusion therapies. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JED FOUNDATION via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act. S.1409--Kids Online Safety Act.
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RESEARCH SOCIETY ON ALCOHOL (FORMERLY KNOWNS AS RESEARCH SOCIETY ON ALCOHOLISM) via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · Q1
Funding for alcohol research and substance use disorders in FY 2024 House and Senate appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLVD HEALTH via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · RR
Promote and educate Congress Administration and Health Organizations on the value of AvertD and other SOLVD products
Promote and educate Congress Administration and Health Organizations on the value of AvertD and other SOLVD products
Promote and educate Congress Administration and Health Organizations on the value of AvertD and other SOLVD products
WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS) via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · RR
Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health Issues, NDAA; telehealth issues.
Issues related to mental health; insurance issues related to Medicare coverage, Medicare Advantage issues; issues related to CMS; issues related to military health TRICARE program, Veterans Health Issues, NDAA; telehealth issues.
AMERICAN AIRLINES, INC. via WILLIAMS AND JENSEN, PLLC
2024 · first_quarter · RR
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
General issues related to patent protections.
Support for obesity drug coverage and access.
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
SANOFI, U.S. via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
RAYNER via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Medicare coverage issue for non-opioid product.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHRMA via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
IP Protections related to trade agreements; trade policies impacting pharaceutical development. Legislative proposals related to WTO TRIPS Waiver.
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals.
PFIZER via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Issues related to pharmaceutical manufacturing and development.
Tax issues affecting the pharmaceutical industry including international tax. Vaccine excise tax issues and VICP.
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals.
ORGANON via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Issues related to prevention of unintended pregnancy and access to contraceptives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEWS MEDIA ALLIANCE via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Issues related to pharmaceutical manufacturing and development.
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
DR. EMIL KAKKIS via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
FDA regulatory review and approval issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Implementation of COVID legislation. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Legislative issues related to insurance markets; ACA implementation issues. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE GREAT OUTDOORS FOUNDATION via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Regional Conservation Partnership Program (RCPP) and 2023 RCPP grants, wetlands and clean water programs. Mississippi River/Gulf of Mexico Hypoxia Task Force.
2023 Farm Bill. "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2023 RCPP grants.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Oceanic & Atmospheric Administration (NOAA), SENATE
IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Funding for river improvements, including modification of dams. Fiscal Year 2024 Transportation-HUD appropriations (H.R. 4820), including community project funding for the Fleur Drive Dam project. Implementation of BUILD Grant.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases.
Matters affecting plasma donation and potential plasma shortages. Issues related to PAHPA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Issues related to therapy services and telehealth.
Proposals to extend coverage and payment for telehealth services after the public health emergency.
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INDIVIOR, INC. via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
General education on issues related to the Drug Enforcement Agency (DEA), issues related to substance abuse addiction and treatment, including NIH/HHS funding levels, Issues related to access to addiction treatments, including telehealth. Support Act Reauthorization.
Tax credits and tax issues related to the pharmaceutical industry.
Policies impacting access to substance abuse treatment.
IRHYTHM TECHNOLOGIES via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Issues related to CMS payment policy and telehealth. Issues related to Medicare technology paid pursuant to the Medicare Physician Fee Schedule. Issues related to Covid 19.
Issues related to artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular health.
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies.
Tax issues related to the pharmaceutical industry.
MT PHARMA AMERICA, INC. via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases; matters affecting infusion therapies. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JED FOUNDATION via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act.
General education about mental health and suicide prevention programs. H.R.5740 - Enhancing Mental Health and Suicide Prevention Through Campus Planning Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RESEARCH SOCIETY ON ALCOHOL (FORMERLY KNOWNS AS RESEARCH SOCIETY ON ALCOHOLISM) via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · Q4
Funding for alcohol research and substance use disorders in FY 2024 House and Senate appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAYNER via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · RA
Williams and Jensen will be lobbying on behalf of ensuring adequate CMS coverage and reimbursement of Rayner's non-opioid product and build support for the reauthorization for the No Plan Act and other related legislations.
DR. EMIL KAKKIS via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · RR
FDA drug approval process for rare diseases, including increased use of biomarkers in the Accelerated Approval Pathway, clinical trial design and other barriers to approval.
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
General issues related to patent protections.
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
SANOFI, U.S. via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
PFIZER via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Tax issues affecting the pharmaceutical industry including international tax. Vaccine excise tax issues and VICP.
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug pricing proposals. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). PASTEUR Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals.
PHRMA via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals.
IP Protections related to trade agreements; trade policies impacting pharaceutical development. Legislative proposals related to WTO TRIPS Waiver.
ORGANON via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Issues related to prevention of unintended pregnancy and access to contraceptives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEWS MEDIA ALLIANCE via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Issues related to pharmaceutical manufacturing and development.
International and domestic tax issues.
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Medicare and Medicaid issues related to physician payment and due process. Physician reimbursement. Policies impacting U.S. address to the Covid-19 pandemic.
Medical liability issues; continuing medical education; graduate medical education; Physician Due Process Rights; general practice issues; corporate practice of medicine. Restrictive Covenants. Policies impacting U.S. address to the Covid-19 pandemic. Non-compete clauses with respect to position practices. H.R. 730, S. 220; scope of practice issues, H.R. 2713, H.R. 618, S.131.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Implementation of COVID legislation. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Legislative issues related to insurance markets; ACA implementation issues. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Telehealth policies. H.R. 3417.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Policies impacting disease prevention.
Issues related to patent protections.
Tax issues related to the pharmaceutical industry.
IRHYTHM TECHNOLOGIES via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Issues related to artificial intelligence.
Issues related to CMS payment policy and telehealth. Issues related to Medicare technology paid pursuant to the Medicare Physician Fee Schedule. Issues related to Covid 19.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Issues related to therapy services and telehealth.
Medicare coverage and reimbursement for therapy services and rehabilitation telehealth services; Medicare payment reform for post-acute care services; Matters affecting bundled payments and value-based reimbursement; Proposals to extend coverage and payment for telehealth services; S2459, the Empower Act HR 4878.
Proposals to extend coverage and payment for telehealth services after the public health emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases.
Matters affecting plasma donation and potential plasma shortages. Issues related to PAHPA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDIVIOR, INC. via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Policies impacting access to substance abuse treatment.
Medicaid Re-Entry Act, policies related to reimbursement of substance use disorder treatment and the Mainstreaming Addiction Treatment Act.
General education on issues related to the Drug Enforcement Agency (DEA), issues related to substance abuse addiction and treatment, including NIH/HHS funding levels, Issues related to access to addiction treatments, including telehealth. Support Act Reauthorization.
THE GREAT OUTDOORS FOUNDATION via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Regional Conservation Partnership Program (RCPP) and 2023 RCPP grants, wetlands and clean water programs.
2023 Farm Bill. "Flood Resiliency and Land Stewardship Act" (H.R. 3972). Regional Conservation Partnership Program and 2023 RCPP grants.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Oceanic & Atmospheric Administration (NOAA), SENATE
IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Funding for river improvements, including modification of dams. Fiscal Year 2024 Transportation-HUD appropriations (H.R. 4820), including community project funding for the Fleur Drive Dam project. Implementation of BUILD Grant.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE
MT PHARMA AMERICA, INC. via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement.
Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JED FOUNDATION via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
General education about mental health and suicide prevention programs.
General education about mental health and suicide prevention programs.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RESEARCH SOCIETY ON ALCOHOL (FORMERLY KNOWNS AS RESEARCH SOCIETY ON ALCOHOLISM) via WILLIAMS AND JENSEN, PLLC
2023 · third_quarter · Q3
Funding for alcohol research and substance use disorders in FY 2024 House and Senate appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAYNER via WILLIAMS AND JENSEN, PLLC
2023 · fourth_quarter · RR
Williams and Jensen will be lobbying on behalf of ensuring adequate CMS coverage and reimbursement of Rayner's non-opioid product and build support for the reauthorization for the No Plan Act and other related legislations.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to patent protections.
Issues related to antitrust legislation
False Claims Act Amendments.
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Policies impacting access to substance abuse treatment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmaceutical manufacturing and development.
Tax issues affecting the pharmaceutical industry including international tax. Vaccine excise tax issues and VICP.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmaceutical development; Policies impacting Medicare Part D; Part B and 340 B programs.
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmaceutical manufacturing and development.
International and domestic tax issues.
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tax credits and tax issues related to the pharmaceutical industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular health.
Tax issues related to the pharmaceutical industry.
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies.
Issues related to antitrust legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General education about mental health and suicide prevention programs. Increased funding for Garrett Lee Smith and Project AWARE mental health and suicide prevention programs
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for obesity drug coverage and access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tax issues affecting the pharmaceutical industry including international tax. Vaccine excise tax issues and VICP.
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmaceutical development; Policies impacting Medicare Part D; Part B and 340 B programs.
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
International and domestic tax issues.
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Policies impacting access to substance abuse treatment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tax issues related to the pharmaceutical industry.
Policies impacting disease prevention.
False Claims Act Amendments.
Issues related to patent protections.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Promote and educate Congress Administration and Health Organizations on the value of AvertD and other SOLVD products
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy.
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 4818, S. 2407.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals.
Issues related to pharmaceutical development; Policies impacting Medicare Part D; Part B and 340 B programs.
Issues related to pharmaceutical manufacturing and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmaceutical manufacturing and development. Legislative proposals related to WTO TRIPS Waiver.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug pricing proposals. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). PASTEUR Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
International and domestic tax issues.
Issues related to pharmaceutical manufacturing and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicaid Re-Entry Act, policies related to reimbursement of substance use disorder treatment and the Mainstreaming Addiction Treatment Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to antitrust legislation
False Claims Act Amendments.
Policies impacting disease prevention.
Issues related to patent protections.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for obesity drug coverage and access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmaceutical manufacturing and development. Legislative proposals related to WTO TRIPS Waiver.
Issues related to pharmaceutical manufacturing and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmaceutical development; Policies impacting Medicare Part D; Part B and 340 B programs.
Issues related to pharmaceutical manufacturing and development.
General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. Policies impacting U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Digital news content and publishing; S. 1094 Journalism Competition and Preservation Act, antitrust issues impacting digital news publishers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407.
Issues related to pharmaceutical manufacturing and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
False Claims Act Amendments.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular health.
Issues related to antitrust legislation
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tax credits and tax issues related to the pharmaceutical industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office